Please log in
You must be logged in to send the contact request.
Manage stand orders
Select Option
NGeneBio Co., Ltd
Rm#307 Daeryung Post-Tower 1 Bldg, 288, Digital-Ro, Guro-Gu,
08390
Seoul
Korea, Republic
Korea, Republic
Submit your contact details
Provide your contact details to the exhibitor. Optionally, you may also add a personal message.
Your name, phone number, and e-mail address are subject to the submission of personal data. Messe Düsseldorf GmbH expressly points out that for a data transmission into third countries, for which no adequacy decision of the EU-commission is on hand certifying an adequate level of protection of personal data, it is not ensured that there are appropriate safeguards for the protection of personal data on hand.
An error has occurred
Please check your internet connection or try again later.
Message has been sent
Your message to the exhibitor was sent successfully.
Contact
YoungJoon Moon
Director of Global Business Division
Email
yj.moon@ngenebio.com
Harold Jung
Team leader of Global sales team
Megan Kim
Sales Manager
Email
megan.kim@ngenebio.com
Kathy Lee
Team Leader of Global marketing science team
Julia Lee
Global marketing scientist
Email
sy.lee@ngenebio.com
Emily Lee
Marketing Scientist
Rosey Jang
Global marketing manager
Email
mihyeon.j@ngenebio.com
Please log in
You must be logged in to use matchmaking
Please log in for matchmaking
Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.
Let's get started!
Welcome to Matchmaking. Would you like to get in touch with ?
Our range of products
Product categories
- 03 Diagnostic tests
- 03.06 Genetic testing, molecular diagnostics
- 03.06.01 DNA testing
DNA testing
- (CE-IVD) NGenePlex™ nCoV qRT-PCR Kit
- (CE-IVD) BRCAaccuTest™ PLUS - NGS test for BRCA1 and BRCA2 mutations
- (CE-IVD) HEMEaccuTest™ DNA/RNA - NGS test for Hematological malignancies
- (CE-IVD) SOLIDaccuTest™ DNA/RNA - NGS test for Solid Tumor (Breast, Lung, Gastric, Colon, etc.)
- Short Tandem Repeat Test - IDaccuTest™
- HLAaccuTest™ - NGS test for Human Leukocyte Antigen Typing
- (CE-IVD) NGeneAnalySys™ for clinical NGS data analysis software
- (CE-IVD) Viral RNA/DNA extraction kit prior to the step of detection of COVID-19
- Antibacterial Copper Film against COVID-19
Our products
(CE-IVD) NGenePlex™ nCoV qRT-PCR Kit
NGenePlex™
- NGenePlex™ nCoV qRT-PCR Kit is a reagent of real-time reverse transcription-polymerase chain reaction (RT-PCR) assay intended for the qualitatively detecting nucleic acid of SARS-CoV-2 from patients infected or suspected of COVID-19.
- NGenePlex™ nCoV qRT-PCR Kit is a reagent of real-time reverse transcription-polymerase chain reaction (RT-PCR) assay intended for the qualitatively detecting nucleic acid of SARS-CoV-2 from patients infected or suspected of COVID-19.
- Target genes: RdRp and N genes on SARS-CoV-2
- Fluorometer Channel: FAM (RdRp), HEX/VIC (N), Cal Red 610/Texas Red (IC: human RNase P)
- CE-IVD marked
- US FDA EUA submission (expected to get approval by the end of 2020)
(CE-IVD) BRCAaccuTest™ PLUS - NGS test for BRCA1 and BRCA2 mutations
BRCAaccuTest™ PLUS is a reagent kit for producing libraries for analyzing the BRCA1 and BRCA2 genes using the next generation sequencing (NGS) method, which analyzes genomic DNA derived from blood or FFPE tissue.
- For breast and ovarian cancer patients
- For HBOC (Hereditary breast and ovarian cancer syndrome) patients
- For family history or the age of breast cancer incidence
- For breast and ovarian cancer patients
- For HBOC (Hereditary breast and ovarian cancer syndrome) patients
- For family history or the age of breast cancer incidence
- Target Enrichment method: Amplicon based method
- NGS platform & reagent kit: illumina MiSeq, MiSeq Dx / MiSeq Reagent Nano kit, v2, 300cycles
- CE-IVD marked
(CE-IVD) HEMEaccuTest™ DNA/RNA - NGS test for Hematological malignancies
Clinical NGS kit for Hematological Malignancies & analysis SW
HEMEaccuTest™ is intended for the molecular genetic tests of multiple genes related to hematologic malignancy.
- Diagnosis through qualitative analysis of hematologic malignancy
- Purpose to assist in appropriate classification and prediction of prognosis
HEMEaccuTest™ is intended for the molecular genetic tests of multiple genes related to hematologic malignancy.
- Diagnosis through qualitative analysis of hematologic malignancy
- Purpose to assist in appropriate classification and prediction of prognosis
- Target Enrichment Method: Hybridization & capture method
- Target genes: 108 genes for DNA panel, 53 genes for RNA panel
- NGS platform & reagent kit: Illumina MiSeq, MiSeq Dx / MiSeq Reagent kit, v3, 300cycles
- CE-IVD marked
(CE-IVD) SOLIDaccuTest™ DNA/RNA - NGS test for Solid Tumor (Breast, Lung, Gastric, Colon, etc.)
Genetic variants screening for solid tumors
- SOLIDaccuTest™ is an excellent tool to explore variants associated with solid tumors using a comprehensive method of next-generation sequencing (NGS). It reflects the latest research trends and is optimized for the medical purpose by selecting essential genes of solid tumors including lung, colon, breast, skin brain, gastric, ovarian cancers, etc.
- Target Enrichment Method: Hybridization & capture method
- Target genes: 84 genes for DNA panel, 29 genes for RNA panel
- NGS platform: Illumina MiSeq, MiSeq Dx / MiSeq Reagent kit, v3, 300cycles
- CE-IVD marked
Short Tandem Repeat Test - IDaccuTest™
- DNA analytical testing methods have been developed and capable of identifying individuals accurately, became a powerful tool in forensic testing, identification of paternity, and personal identification tests for family relationships.
- NGenBio has launched IDaccuTest™ kits which fulfill all the needs and requirements for genetic profiling, compatible with various Sanger sequencers with affordable price.
- Paternity/maternity testing
- Sibling testing
- Missing child identification
- Record and Preserve the Integrity of your Family Tree
- Matching identification
- Blood or bone marrow transplant
HLAaccuTest™ - NGS test for Human Leukocyte Antigen Typing
HLAaccuTest™ is an in vitro diagnostic medical device for HLA (human leukocyte antigen) typing that can identify high-resolution histocompatibility antigens using next-generation sequencing.
- Organ transplant including hematopoietic stem cell transplant
- Autoimmune disease including ankylosing spondylitis
- Screening for chronic infectious diseases and a drug hypersensitivity reaction
- Organ transplant including hematopoietic stem cell transplant
- Autoimmune disease including ankylosing spondylitis
- Screening for chronic infectious diseases and a drug hypersensitivity reaction
- Target Enrichment method: Amplicon (Long-range PCR)
- Sequencing platform: Illumina MiSeq / MiSeqDx
- Sequencing Reagent: MiSeq Reagent nano Kit, v2 ( up to 6 samples/run), MiSeq Reagent micro Kit, v2 ( up to 24 samples/run)
- Analysis software: EasyHLAanalyzer™ (the optimised software for HLAaccuTest)
- CE-IVD planned in 1Q/2021
(CE-IVD) NGeneAnalySys™ for clinical NGS data analysis software
NGeneAnalySys™ is a software for analysis of the genetic testing data produced by next-generation sequencing (NGS) and helps to report in clinical-grade for oncology tests. It provides accurate pathogenic variants information based on ACMG guidelines and relevant therapy information based on the database(solid tumor / hematologic malignancies), which enables efficient on-site data analysis for clinical NGS. NGeneBio offers NGeneAnalySys™ SW with validated NGS panels for integrated clinical NGS solution oncology solutions.
<Key point>
- Compliance with ACMG guideline for NGS clinical use
- Use lots of databases and In Silico prediction for accurate interpretation (Reference sequence DB/ Population DB/ Cancer specific DB/ Constitutional variant DB/ Internal DB)
- Provides QC report on sample data
- Create a clinical-grade report of variants analysis
<Key point>
- Advanced analytical platform
- Compliance with ACMG guideline for NGS clinical use
- Use lots of databases and In Silico prediction for accurate interpretation (Reference sequence DB/ Population DB/ Cancer specific DB/ Constitutional variant DB/ Internal DB)
- Analysis and clinical report
- Provides QC report on sample data
- Create a clinical-grade report of variants analysis
- CE-IVD marked
(CE-IVD) Viral RNA/DNA extraction kit prior to the step of detection of COVID-19
MVPrep™ Kit Series (Powered by NGeneBio)
DO NOT waste your time to be accustomed to a complicated extraction kit.
TRY MVPrep’s syndromic approach, SAVE your time for more valuable investigation.
DO NOT waste your time to be accustomed to a complicated extraction kit.
TRY MVPrep’s syndromic approach, SAVE your time for more valuable investigation.
- Plasmid/Fragment
● Plasmid
● GEL Clean-up
● PCR Clean-up
- MVPrep™Plasmid Kit
- MVPrep™ GEL Clean-Up Kit
- MVPrep™ PCR Clean-Up Kit - Genomic DNA
● Blood/Tissue/FFPE/Cell/Bacteria/Plant
- MVPrep™ Blood gDNA Kit
- MVPrep™ Tissue/Cell/Bacteria/Blood gDNA Kit
- MVPrep™ gDNA Kit
- MVPrep™ Plant DNA Kit - RNA
● Total RNA
● Viral RNA/DNA
● Plant RNA
- MVPrep™ Total RNA Plus Kit
- MVPrep™ Viral RNA/DNA Kit
- MVPrep™ Plant RNA Kit - Related items
● DNA Ladder/Agarose/Oligo
- MVPCheck™ 100bp DNA ladder (with 6X loading dye)
- MVPCheck™ 1kb Plus DNA ladder (with 6X loading dye)
- Oligo MarV™ Oligo(dT)15 Primer (PAGE Purification)
Antibacterial Copper Film against COVID-19
SuperCOPPER Antibacterial Film (Powered by NGeneBio)
- Non-adhesive type
- Adhesive type
✓ Made in Korea
✓ 99.9% antibacterial product
✓ Various applications (Any surfaces you touch such
as cell phone, handle, the button of elevator, handrail of
moving walk/escalator, etc.)
✓ Easy to use (Measure, cut, and Paste!)
About us
Company portrait
NGeneBio was founded in October 2015 as a joint venture between Genecurix and Korea Telecom, develops in vitro diagnostics (IVD) / companion diagnostics (CDx) products and bioinformatics software with cutting-of-edge technologies including next generation sequencing (NGS).
The company launched NGS-based hereditary breast / ovarian cancer panel (BRCAaccuTest™) with clinical analysis S/W (NGeneAnalysis™) and received CE-IVD mark in Jun/2017.
We have been working on research and development with the cooperation of the anticancer diagnosis project team, domestic and foreign hospitals and biotech companies. We have been striving to secure the technology and develop business model of mid- to long-term perspectives through external patent license-in in addition to the company’s own patent discovery.
We are doing our utmost to achieve our goal of global healthcare service provider based on four core values of challenging execution, respect for life, human resource development and customer trust, and we look forward to your continued support and interest
The company launched NGS-based hereditary breast / ovarian cancer panel (BRCAaccuTest™) with clinical analysis S/W (NGeneAnalysis™) and received CE-IVD mark in Jun/2017.
We have been working on research and development with the cooperation of the anticancer diagnosis project team, domestic and foreign hospitals and biotech companies. We have been striving to secure the technology and develop business model of mid- to long-term perspectives through external patent license-in in addition to the company’s own patent discovery.
We are doing our utmost to achieve our goal of global healthcare service provider based on four core values of challenging execution, respect for life, human resource development and customer trust, and we look forward to your continued support and interest